report cover1

Radiopharmaceuticals Market “(By Type: Diagnostic and Therapeutic); By Application (Neurology, Cardiology, Oncology and Others); (By End user: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes and Others)” - Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2030

A prominent research firm, Cognizance Market Research added a cutting-edge industry report on “Radiopharmaceuticals Market”. The report studies the current as well as past growth trends and opportunities for the market to gain valuable insights during the forecast period from 2022 to 2030.

Radiopharmaceuticals Market Analysis

According to cognizance market research the radiopharmaceuticals market is anticipated to reach US$ 11,600.49 Million by the end of 2030 from US$ 5,125.25 Million in 2022, expanding at a CAGR of 10.8% over the forecast period that is 2023 to 2030.

radiopharmaceuticals market

What are Radiopharmaceuticals?

Radiopharmaceuticals are radioactive drugs (radioisotopes) used in the prevention or treatment of cancer. These drugs can be administered orally (as pills), intravenously (by injection into a patient’s vein), or intramuscularly (inserted into a cavity in the body). Despite the fact that nuclear medicine specialists are required to provide the medications, radiopharmacology is nonetheless regulated as a subspecialty of radiation therapy. Every radiopharmaceutical is intended to go to a certain location within the body. It will discharge radioactive substances after it has reached its target, which will kill the tumour cells. Thyroid cancer, brain cancer, lymphoma, and tumours that have migrated to the bones are among the cancers that radiopharmaceuticals can currently target, according to study. Because oncologists can monitor radioactivity in the body after the medications are taken to check for cancer, radiopharmaceuticals can also be used to diagnose some cancers. A gamma camera or some comparable gamma imaging device must be used for this, as it calls for a specialised imaging system. Radiopharmaceuticals are referred to as “tracers” when they are utilised for diagnostic reasons. Radiation levels in diagnostic radiopharmaceuticals are lower than in therapeutic radiopharmaceuticals.

Radiopharmaceuticals Market Outlook

The radiopharmaceutical market is expected to be primarily driven by increasing radio-therapeutic penetration. The use of radiopharmaceuticals in the diagnosis and treatment of a wide range of illnesses, such as cancer, cardiovascular disease, and neurological issues, is growing quickly. Radiopharmaceuticals are often utilised in the treatment of a number of disorders because of the features of radioactive decay and the potential for focused therapeutic irradiation. The rare COVID-19 epidemic, however, restrained market growth.

Worldwide manufacture of radioisotopes has ended, as have research efforts. The demand and supply chains were disrupted, which led to a decrease in the value of the global market. The market will develop significantly as a result of the quick adoption of advanced nuclear imaging technologies like SPECT and Positron Emission Tomography (PET). Increased research and development from key players is assisting the market expansion of radiopharmaceuticals.

Segment Analysis:

The radiopharmaceuticals market has been segmented into type, application, and geography. Based on type the Radiopharmaceuticals market is segmented into diagnostic and therapeutic.

On the basis of application, radiopharmaceuticals market is segmented into neurology, cardiology, oncology and others.

On the basis of end user, radiopharmaceuticals market is segmented into Hospitals, Ambulatory Surgical Centres, Diagnostic Centres, Cancer Research Institutes and Others.

Geographical Analysis:

North America, Europe, Asia-Pacific, and the rest of the world are covered in the study’s market insights by region. The market is anticipated to expand as a result of the region’s rapid adoption of efficient nuclear imaging technologies as well as the growing use of technically complex and cutting-edge therapeutic radiopharmaceuticals. Also, it is projected that during the projection period, there will be an increase in the prevalence of various cancers as well as other chronic illnesses, which will support market growth in North America.

geographical analysis

The report offers the revenue of the Radiopharmaceuticals market for the period 2020-2030, considering 2020 & 2021 as a historical year, 2022 as the base year and 2023 to 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the Radiopharmaceuticals market for the forecast period. The Radiopharmaceuticals market report provides insights and in-depth analysis into developments impacting enterprises and businesses on a regional and global level. The report covers the Radiopharmaceuticals market performance in terms of revenue contribution from several segments and comprises a detailed analysis of key drivers, trends, restraints, and opportunities prompting revenue growth of the Radiopharmaceuticals market.

The report has been prepared after wide-ranging secondary and primary research. Secondary research included internet sources, numerical data from government organizations, trade associations, and websites. Analysts have also employed an amalgamation of bottom-up and top-down approaches to study numerous phenomena in the Radiopharmaceuticals market. Secondary research involved a detailed analysis of significant players’ product portfolio. Literature review, press releases, annual reports, white paper, and relevant documents have been also studied to understand the Radiopharmaceuticals market. Primary research involved a great extent of research efforts, wherein experts carried out interviews telephonic as well as questioner-based with industry experts and opinion-makers.

The report includes an executive summary, along with a growth pattern of different segmented included in the scope of the study. The Y-o-Y analysis with elaborate market insights has been provided in the report to comprehend the Y-o-Y trends in the Radiopharmaceuticals market. Additionally, the report focuses on altering competitive dynamics in the global market. These indices serve as valued tools for present market players as well as for companies interested in participating in the Radiopharmaceuticals market. The subsequent section of the Radiopharmaceuticals report highlights the USPs, which include key industry events (Type launch, research partnership, acquisition, etc.), technology advancements, pipeline analysis, prevalence data, and regulatory scenario.

Radiopharmaceuticals Market Competitive Landscape

The “Radiopharmaceuticals Market” study report will provide a valuable insight with an emphasis on global market including some of the major players such as:

  • Advanced Accelerator Applications, A Novartis Company
  • Bayer AG
  • Bracco
  • B. Braun SE
  • Cardinal Health
  • Curium
  • Eckert & Ziegler
  • Eczacıbaşı-Monrol
  • General Electric
  • Hanger Clinic
  • Isotope JSC
  • Lantheus
  • Nordion (Canada)
  • NMR

The report explores the competitive scenario of the Radiopharmaceuticals market. Major players operating in the Radiopharmaceuticals market have been identified and profiled for unique commercial attributes. Company overview (company description, Type portfolio, geographic presence, employee strength, Key management, etc.), financials, SWOT analysis, recent developments, and key strategies are some of the features of companies profiled in the Radiopharmaceuticals market report.


Radiopharmaceuticals Market, by Product Type

  • Diagnostic
  • Therapeutic

Radiopharmaceuticals Market, by Application

  • Neurology
  • Cardiology
  • Oncology
  • Others

Radiopharmaceuticals Market, by End user

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Cancer Research Institutes
  • Others

Radiopharmaceuticals Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia & New Zealand
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
Complete the form below and we'll get back to you shortly
Table of Content

Research Methodology: Aspects

Market research is a crucial tool for organizations aiming to navigate the dynamic landscape of customer preferences, business trends, and competitive landscapes. At Cognizance Market Research, acknowledging the importance of robust research methodologies is vital to delivering actionable insights to our clientele. The significance of such methodologies lies in their capability to offer clarity in complexity, guiding strategic management with realistic evidence rather than speculation. Our clientele seek insights that excel superficial observations, reaching deep into the details of consumer behaviours, market dynamics, and evolving opportunities. These insights serve as the basis upon which businesses craft tailored approaches, optimize product offerings, and gain a competitive edge in an ever-growing marketplace.

The frequency of information updates is a cornerstone of our commitment to providing timely, relevant, and accurate insights. Cognizance Market Research adheres to a rigorous schedule of data collection, analysis, and distribution to ensure that our reports reflect the most current market realities. This proactive approach enables our clients to stay ahead of the curve, capitalize on emerging trends, and mitigate risks associated with outdated information.

Our research process is characterized by meticulous attention to detail and methodological rigor. It begins with a comprehensive understanding of client objectives, industry dynamics, and research scope. Leveraging a combination of primary and secondary research methodologies, we gather data from diverse sources including surveys, interviews, industry reports, and proprietary databases. Rigorous data analysis techniques are then employed to derive meaningful insights, identify patterns, and uncover actionable recommendations. Throughout the process, we remain vigilant in upholding the highest standards of data integrity, ensuring that our findings are robust, reliable, and actionable.

Key phases involved in in our research process are mentioned below:


Understanding Clients’ Objectives:

Extensive Discussions and Consultations:

  • We initiate in-depth discussions and consultations with our clients to gain a comprehensive understanding of their objectives. This involves actively listening to their needs, concerns, and aspirations regarding the research project.
  • Through these interactions, we aim to uncover the underlying motivations driving their research requirements and the specific outcomes they hope to achieve.

Industry and Market Segment Analysis:

  • We invest time and effort in comprehensively understanding our clients’ industry and market segment. This involves conducting thorough research into market trends, competitive dynamics, regulatory frameworks, and emerging opportunities or threats.
  • By acquiring a deep understanding of the broader industry landscape, we can provide context-rich insights that resonate with our clients’ strategic objectives.

Target Audience Understanding:

  • We analyze our clients’ target audience demographics, behaviors, preferences, and needs to align our research efforts with their consumer-centric objectives. This entails segmenting the audience based on various criteria such as age, gender, income level, geographic location, and psychographic factors.
  • By understanding the nuances of the target audience, we can tailor our research methodologies to gather relevant data that illuminates consumer perceptions, attitudes, and purchase intent.


Identifying Challenges and Opportunities:

  • We proactively identify the challenges and opportunities facing our clients within their respective industries. This involves conducting SWOT (Strengths, Weaknesses, Opportunities, Threats) analyses and competitive benchmarking exercises.
  • By identifying potential obstacles and growth drivers, we can provide strategic recommendations that help our clients navigate complexities and capitalize on emerging opportunities effectively.

Grasping Specific Goals:

  • We delve into the intricacies of our clients’ objectives to gain clarity on the specific goals they aim to accomplish through the research. This entails understanding their desired outcomes, such as market expansion, product development, or competitive analysis.
  • By gaining a nuanced understanding of our clients’ goals, we can tailor our research approach to address their unique challenges and opportunities effectively.

Data Collection:


Primary Research Process:

  • Surveys: We design and administer surveys tailored to capture specific information relevant to our clients’ objectives. This may involve employing various survey methodologies, such as online, telephone, or face-to-face interviews, to reach target audiences effectively.
  • Interviews: We conduct structured or semi-structured interviews with key stakeholders, industry experts, or target consumers to gather in-depth insights and perspectives on relevant topics. These interviews allow us to probe deeper into specific issues and uncover valuable qualitative data.
  • Focus Groups: We organize focus group discussions with carefully selected participants to facilitate interactive discussions and gather collective opinions, attitudes, and preferences. This qualitative research method provides rich contextual insights into consumer behaviors and perceptions.
  • Observations: We conduct observational research by directly observing consumer behaviors, interactions, and experiences in real-world settings. This method enables us to gather objective data on consumer actions and reactions without relying on self-reported information.

Secondary Research Process:

  • Literature Review: We conduct comprehensive literature reviews to identify existing studies, academic articles, and industry reports relevant to the research topic. This helps us gain insights into previous research findings, theoretical frameworks, and best practices.
  • Industry Reports: We analyze industry reports published by reputable trade associations (whitepapers, research studies, etc.), and government agencies (U.S. Census Bureau, Bureau of Labor Statistics, and Securities and Exchange Commission etc.) to obtain macro-level insights into market trends, competitive landscapes, and industry dynamics.
  • Government Publications: We review government publications, such as economic reports, regulatory documents, and statistical databases, to gather relevant data on demographics, market size, consumer spending patterns, and regulatory frameworks.
  • Online Databases: We leverage online databases, such as industry portals, and academic repositories (PubMed Central (PMC), ScienceDirect, SSRN (Social Science Research Network), Directory of Open Access Journals (DOAJ), NCBI, etc.), to access a wide range of secondary data sources, including market statistics, financial data, and industry analyses.





Data Analysis:

The data analysis phase serves as a critical juncture where raw data is transformed into actionable insights that inform strategic decision-making. Through the utilization of analytical methods such as statistical analysis and qualitative techniques like thematic coding, we uncover patterns, correlations, and trends within the data. By ensuring the integrity and validity of our findings, we strive to provide clients with accurate and reliable insights that accurately reflect the realities of the market landscape.



Transformation of Raw Data:

  • Upon collecting the necessary data, we transition into the data analysis phase, where raw data is processed and transformed into actionable insights. This involves organizing, cleaning, and structuring the data to prepare it for analysis.

Utilization of Analytical Methods:

  • Depending on the research objectives, we employ a diverse range of analytical methods to extract meaningful insights from the data. These methods include statistical analysis, trend analysis, regression analysis, and qualitative coding.

Statistical Analysis:

  • Statistical tools are instrumental in uncovering patterns, correlations, and trends within the data. By applying statistical techniques such as descriptive statistics, hypothesis testing, and multivariate analysis, we can discern relationships and derive valuable insights.

Qualitative Analysis Techniques:

  • In addition to quantitative analysis, we leverage qualitative analysis techniques to gain deeper insights from qualitative data sources such as interviews or open-ended survey responses. One such technique is thematic coding, which involves systematically categorizing and interpreting themes or patterns within qualitative data.

Integrity and Validity Maintenance:

  • Throughout the analysis process, we maintain a steadfast commitment to upholding the integrity and validity of our findings. This entails rigorous adherence to established methodologies, transparency in data handling, and thorough validation of analytical outcomes.

Data Validation:

The final phase of our research methodology is data validation, which is essential for ensuring the reliability and credibility of our findings. Validation involves scrutinizing the collected data to identify any inconsistencies, errors, or biases that may have crept in during the research process. We employ various validation techniques, including cross-referencing data from multiple sources, conducting validity checks on survey instruments, and seeking feedback from independent experts or peer reviewers. Additionally, we leverage internal quality assurance protocols to verify the accuracy and integrity of our analysis. By subjecting our findings to rigorous validation procedures, we instill confidence in our clients that the insights they receive are robust, reliable, and trustworthy.


Importance of Data Validation:

  • Data validation is the final phase of the research methodology, crucial for ensuring the reliability and credibility of the findings. It involves a systematic process of reviewing and verifying the collected data to detect any inconsistencies, errors, or biases.

Scrutiny of Collected Data:

  • The validation process begins with a thorough scrutiny of the collected data to identify any discrepancies or anomalies. This entails comparing data points, checking for outliers, and verifying the accuracy of data entries against the original sources.

Validation Techniques:

  • Various validation techniques are employed to ensure the accuracy and integrity of the data. These include cross-referencing data from multiple sources to corroborate findings, conducting validity checks on survey instruments to assess the reliability of responses, and seeking feedback from independent experts or peer reviewers to validate the interpretation of results.

Internal Quality Assurance Protocols:

  • In addition to external validation measures, internal quality assurance protocols are implemented to further validate the accuracy of the analysis. This may involve conducting internal audits, peer reviews, or data validation checks to ensure that the research process adheres to established standards and guidelines.

Report Scope:



Market Size

US$ 11,600.49 Million (2030)

Compound Annual Growth Rate (CAGR)


Base Year


Forecast Period


Forecast Units

Value (US$ Million)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Geographies Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Countries Covered

U.S., Canada, Germany, U.K., France, Spain, Italy, Rest of Europe, Japan, China, India, Australia & New Zealand, South Korea, Rest of Asia Pacific, Brazil, Mexico, Rest of Latin America, GCC, South Africa, Rest of Middle East & Africa

Key Companies Profiled

Advanced Accelerator Applications, A Novartis Company, Bayer AG, Bracco, B. Braun SE, Cardinal Health, Curium, Eckert & Ziegler, Eczacıbaşı-Monrol, General Electric, Hanger Clinic, Isotope JSC, Lantheus, Nordion (Canada), NMR

Key Questions Answered in Radiopharmaceuticals Market Report

Radiopharmaceuticals are radioactive drugs that are used to diagnose and treat diseases. They are made by attaching radioactive isotopes to molecules that can target specific organs or tissues in the body. Radiopharmaceuticals can be administered orally, intravenously, or intramuscularly.

Radiopharmaceuticals can be classified into two main types: diagnostic and therapeutic.

  • Diagnostic radiopharmaceuticals are used to image organs and tissues in the body to diagnose diseases.
  • Therapeutic radiopharmaceuticals are used to treat diseases, such as cancer, by delivering radiation to the diseased tissue.

Radiopharmaceuticals work by binding to specific targets in the body and emitting radiation. This radiation can be used to image organs and tissues, or it can be used to kill cancer cells.

Radiopharmaceuticals offer several benefits over traditional treatments, such as chemotherapy and radiation therapy. They are often more targeted and effective, and they generally have fewer side effects.

The future outlook for the radiopharmaceuticals market is positive. The market is expected to grow rapidly in the coming years, driven by factors such as the increasing prevalence of cancer, the rising demand for targeted therapies, and the development of new radiopharmaceutical treatments for a wider range of diseases.

Single User - $4,600.00

It allows one person, the buyer, to have the sole rights and access to the purchased report. Further distribution of the product is strictly prohibited.

It allows the purchased product to be shared among 1-7 employees of your organization within the same geographical location.

It allows the purchased product to be shared among all employees of your organization irrespective of their geographical location.

Need a Custom Report?

We can customize every report – free of charge – including purchasing stand-alone sections or country-level reports

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Business Development

small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
Ask an Expert